Search results

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee. 

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Neutron scattering instruments used by Japanese researchers.

Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

Professor Vanessa Peterson, Senior Principal Research and Neutron Scattering Instrument Scientist and Leader of the Energy Materials Research project, has been awarded the Bob Cheary Award or Excellence in Diffraction Analysis by the Australian X-ray Analytical Association. She is the first female to be chosen for the award.

The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.